CD44 and neoplasm: In vitro and in vivo studies showed that downregulation of CD44 expression reduces the migratory and invasive potential of OC cells, halting tumor growth as well as peritoneal dissemination; by contrast, overexpression of CD44 has been found in relapsed/recurrent tumors of xenograft mice models treated with taxane-based chemotherapy.